Ng C S, Yost A, Streem S B
Department of Urology, Cleveland Clinic Foundation, Ohio 44195, USA.
J Urol. 2000 Mar;163(3):726-9.
We evaluate the role of contemporary urological intervention in patients with nephrolithiasis associated with autosomal dominant polycystic kidney disease.
Intervention for upper tract stones associated with autosomal dominant polycystic kidney disease was performed in 5 women and 2 men 29 to 65 years old (mean age 47). Indications for intervention consisted of flank pain in 6 patients and/or hematuria in 2. A total of 12 procedures (mean 1.7 per patient) were performed, including shock wave lithotripsy in 6 patients, percutaneous nephrolithotomy in 2, retrograde endoscopy or manipulation in 3 and extended pyelonephrolithotomy in 1.
All patients were rendered stone-free or had only residual "dust." Hospital stay for 5 patients was 1 night or less and there were no complications. Renal function for each patient was stable or improved as measured by serum creatinine.
Most patients with autosomal dominant polycystic kidney disease who require intervention for nephrolithiasis can be safely and effectively treated with essentially any or all contemporary, minimally invasive techniques. The choice of intervention can be based primarily on size and location of the upper tract stones rather than the associated presence of polycystic kidneys.
我们评估当代泌尿外科干预措施在常染色体显性多囊肾病合并肾结石患者中的作用。
对5名女性和2名男性(年龄29至65岁,平均年龄47岁)的常染色体显性多囊肾病相关上尿路结石进行了干预。干预指征包括6例患者的胁腹痛和/或2例患者的血尿。总共进行了12次手术(平均每位患者1.7次),其中6例患者接受了冲击波碎石术,2例接受了经皮肾镜取石术,3例接受了逆行内镜检查或操作,1例接受了扩大肾盂切开取石术。
所有患者结石清除或仅残留“结石碎屑”。5例患者住院时间为1晚或更短,且无并发症。通过血清肌酐测量,每位患者的肾功能稳定或改善。
大多数需要对肾结石进行干预的常染色体显性多囊肾病患者可以通过基本上任何或所有当代微创技术进行安全有效的治疗。干预措施的选择主要可以基于上尿路结石的大小和位置,而非多囊肾的合并存在情况。